recombinant human antihemophilic factor

recombinant human antihemophilic factor

Hematology A recombinant factor VIII for treating hemophilia A. See Hemophilia A.
References in periodicals archive ?
The pharmacokinetics of rVIII-SingleChain compared with recombinant human antihemophilic factor VIII (octocog alfa) were also studied.
The AFFINITY Phase I/III study is an open-label, multi-center trial that examines the crossover safety, efficacy and pharmacokinetics of recombinant coagulation single-chain factor VIII compared with recombinant human antihemophilic factor VIII (octocog alfa).
About the AFFINITY Phase I/III Study The Phase I/III study is an open-label, multi-center trial that examines the crossover safety, efficacy and pharmacokinetics of recombinant coagulation single-chain factor VIII compared with recombinant human antihemophilic factor VIII (octocog alpha).
Full browser ?